Macko Todd D's Form 4 filing
Impact Biomedical Inc. (IBO) · filed Mar 30, 2026
- Accession no.
- 0001493152-26-013708
- Filed
- Mar 30, 2026
- Trade date
- Mar 25-27, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $25.3K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Macko Todd DCIK 0001830744 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | Common Stock | SSaleDisposed | −1,600 | $0.60 | −$960 | 198,122 | Direct | |
| Mar 27, 2026 | Common Stock | SSaleDisposed | −43,400 | $0.56 | −$24,304 | 155,122 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.